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ABSTRACT
Strongyloidiasis is a human parasitic disease caused by the helminth Strongyloides 
stercoralis whose treatment is particularly difficult in immunosuppressed patients due to 
their low responsiveness to conventional therapy. Carica papaya and its isolated compounds 
benzyl isothiocyanate, carpaine and carpasemine are promising compound for the treatment 
of Strongyloides infections due to their anthelmintic action. This study aims to examine the in 
vitro ovicidal and larvicidal activity of C. papaya seed hexane extract against Strongyloides 
venezuelensis, using egg hatching tests and larval motility tests as efficiency markers. The 
crude extract at the concentrations of 566 – 0.0566 mg/mL or the control with albendazole 
(0.025 mg/mL) and negative controls (water and PBS) were incubated with an equal volume 
of egg suspension (± 50 specimens) followed by counting of the specimens after 48 h. The 
same extract and dilutions were added to L3 larvae suspensions (±50 specimens) followed 
by analysis of larvae viability after 24, 48, and 72 h. The extract inhibited egg hatching with 
high efficiency at concentrations of 56.6 mg/mL (95.74%) and 5.66 mg/mL (92.16%). At 
the concentrations of 566 mg/mL (100%) and 56.66 mg/mL (97.32%), the extract inhibited 
larval motility as effectively as ivermectin (0.316 mg/mL; 100%), and more effectively than 
the other dilutions and the negative controls. The larvicidal effect depended on the extract 
concentration, but not on the treatment period. Therefore, C. papaya seed hexane extract 
has anthelmintic potential against S. venezuelensis and is a promising compound for the 
development of phytotherapies to treat strongyloidiasis.
KEYWORDS: Carica papaya. Seed extract. Egg hatching test. Larval motility test. 
Anthelmintic activity. Strongyloidiasis. Strongyloides stercoralis. Strongyloides venezuelensis. 
INTRODUCTION
Strongyloides sp. is an intestinal parasite that can cause potentially fatal 
disseminated infections in immunocompromised patients, such as those under 
corticosteroids therapy, malnourished patients, or those presenting with concomitant 
underlying diseases caused by the human immunodeficiency virus (HIV) and the 
human lymphotropic T-virus (HTLV)1. The current synthetic drugs prescribed for 
the treatment of strongyloidiasis are albendazole, thiabendazole, mebendazole and 
ivermectin2,3. The low efficacy in long-term treatments, malabsorption in cases of 
disseminated disease and undesirable, sometimes serious adverse effects of these 
drugs have reduced their effectiveness2-5.
In general, parasite resistance to medications routinely used in clinical practice 
has prompted the search for new alternatives, including the use of plant-derived 
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extracts containing antiparasitic compounds6,7. C. papaya 
stands out among the plants used for the production of folk 
medicines due to its anthelmintic action, as established in a 
preliminary survey about the control of intestinal parasites 
in Africa8. The anthelmintic activity of this plant has been 
attributed to carpasemine, carpaine-like alkaloids and seed 
glucosinolates that yield benzyl isothiocyanate, which 
exert ovicidal and larvicidal effects9,10. C. papaya latex and 
purified papain are effective against S. venezuelensis eggs 
and larvae and can be used as therapeutic alternatives for the 
control of strongyloidiasis7. Considering the anthelmintic 
potential of C. papaya against other gastrointestinal 
nematodes, the present study aims to examine the in vitro 
ovicidal and larvicidal activity of C. papaya seeds hexane 
extract against S. venezuelensis.
MATERIALS AND METHODS
S. venezuelensis eggs and larvae
The S. venezuelensis strain used in this study was 
maintained by serial passages of infective larvae (L3) 
in Wistar rats (Rattus novergicus) by subcutaneous 
inoculation. The Ethics Committee for Animal Use of the 
Universidade Federal de Uberlandia (Uberlandia, MG, 
Brazil) approved the study (protocol Nº 075/2008). Faeces 
from infected animals were used for egg collection and 
charcoal culture (72 h at 28 ºC) to obtain infective larvae 
(L3) through the Rugai method11.
Preparation of C. papaya seed extract
The Botany Laboratory of the Universidade Federal 
de Goias (Jatai, GO, Brazil) confirmed the identity of the 
commercially available mature C. papaya fruits used in this 
study. They corresponded to the C. papaya species deposited 
at the Herbario Jataiense (Jatai, GO, Brazil, voucher Nº 981). 
Approximately 80 g of C. papaya seeds were removed from 
mature fruits, washed with water to remove pulp residues 
and dried at room temperature for five days. Then, about 
76 g of dry seeds were crushed in a crucible and submitted 
to extraction in a Soxhlet apparatus for 24 h at 68 °C, using 
hexane as a solvent. After filtration through filter paper, the 
filtrate was transferred to a rotary evaporator at 50 °C to 
remove the solvent (hexane). The crude seed extract was 
serially diluted in phosphate buffered saline (PBS) to prepare 
concentrations ranging from 566 mg/mL to 0.0566 mg/mL.
Egg hatching test
The ovicidal activity of the crude extract was analysed 
using the egg hatching test reported by Coles et al.12, 
with some modifications. Faeces from rats infected with 
S. venezuelensis were homogenized in water and filtered 
through a 50 µm sieve. After 15 min of sedimentation, the 
number of eggs was counted using an optical microscope 
and the concentration of the suspension was adjusted to 
1 egg per µL of filtrate. Then, 50 µL of the suspension 
were incubated in Eppendorf tubes with 50 µL of the crude 
seed extract and its dilutions in PBS, for 48 h at 28 ºC. An 
albendazole solution (0.025 mg/mL)13 was used as the 
positive control, while filtered water or PBS were used 
as negative controls. A 10% formaldehyde solution was 
added to the mixture and the number of eggs and larvae 
were counted using an optical microscope at 100 and 400× 
magnification. To analyse the integrity of the specimens, 
images were captured at 400× magnification using a Leica® 
camera, model DS750. All the tests were performed in 
triplicate for each concentration.
Larval motility test
The larval motility test was performed as reported by 
Cordeiro et al.14, with some modifications. S. venezuelensis 
infective larvae (L3) were recovered from charcoal culture11, 
and the concentration of the suspension was adjusted to 1 
larvae per µL of PBS. Then, 100 µL of the suspension were 
transferred to Eppendorf tubes and mixed with 100 µL of the 
crude seed extract and its dilutions in PBS. The ivermectin 
solution (0.316 mg/mL) was used as the positive control15 
and filtered water and PBS were used as negative controls. 
The samples were incubated in triplicate for 24, 48, and 
72 h, at 28 ºC, and larval motility was analysed using an 
optical microscope at 100× magnification.
Data analysis
The efficiency of inhibition of egg hatching (EHT) by 
the extract was calculated using the formula reported by 
Wood et al.16: 
EHT (%) = [(number of eggs/(number of eggs + number 
of larvae)] × 100
The percentage of inhibition of larval motility (LMT) 
by each extract dilution was calculated using the formula 
adapted from Al-Rofaai et al.17: 
LMT (%) = [(%) motility in the treatment group – 
(%) motility in the negative control)/(100 – (%) motility 
in the negative control)] × 100.
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Data from both tests were submitted to logarithmic 
and non-linear regression analyses to determine the extract 
half-maximal inhibitory concentration (DL50). Significant 
differences among the extract concentrations, the negative 
controls and the positive control were analysed using 
the Fisher’s exact test. One-way analysis of variance 
(ANOVA) combined with the Kruskal-Wallis test was 
used to compare the mobile and total larvae counts after 
treatment for different periods and with different extract 
concentrations. Data were analysed using the statistical 
package of the GraphPad Prism software, version 5.0 for 
Windows (GraphPad Software Inc. California, USA). 
Differences among experimental outcomes were considered 
as statistically significant when p < 0.05. All the experiments 
were carried out in triplicate.
RESULTS
Analysis of the percentage of S. venezuelensis egg 
hatching indicated that C. papaya seed extract at 56.6 mg/mL 
and 5.66 mg/mL had the strongest inhibitory effects on 
egg hatching: 95.74% (± 1.77) and 92.16% (± 2.18), 
respectively; these effects were similar to that achieved after 
treatment with 0.025 mg/mL albendazole (positive control) 
(Figure 1A). Treatment with the extract at these dilutions 
or albendazole inhibited egg hatching more effectively than 
the negative controls containing water and PBS (p < 0.01).
The extract exerted a concentration-dependent 
inhibitory effect on egg hatching (Figure 1B), and resulted 
in a DL50 = 78.14 mg/mL. The C. papaya seed extract in its 
crude form and at a concentration of 566 mg/mL, lysed all 
Figure 1 - Inhibition of Strongyloides venezuelensis eggs hatching by Carica papaya seed hexane extract. (A) Percentage of 
inhibition of eggs hatching determined after treatment of 50 specimens with different extract concentrations (566-0.0566 mg/mL) 
for 48 h, at 28 ºC. Negative controls: water and PBS. Positive control: albendazole at 0.025 mg/mL. The analysis of TEO efficiency 
between the concentrations tested and the positive and negative controls was performed by the Fisher’s exact test. (B) Non-linear 
regression curve for inhibition of eggs hatching as a function of extract concentration. Results are expressed as mean ± standard 
error of triplicate measurements. * p < 0.05; ** p < 0.01; *** p < 0.0001.
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or most of the S. venezuelensis specimens when compared 
with the other dilutions (Figure 2). The inhibitory effects 
of the extract at concentrations lower than 0.566 mg/mL 
were not significantly different from each other (p > 0.05).
Larval motility of S. venezuelensis L3 larvae was 
analysed in vitro after 24, 48, and 72 h of treatment with C. 
papaya seed extract (Figure 3). The extract at 566 mg/mL 
and 56.6 mg/mL suppressed larval motility as effectively 
as 0.316 mg/mL of ivermectin (positive control), resulting 
in 100% (± 0.0), 97.32% (± 2.68) and 100% (± 0.0), 
respectively, and was a little more effectively than the 
extract at 5.66 mg/mL (p < 0.05) (Figure 3A). Treatment 
with the extract at 0.566 mg/mL and 0.0566 mg/mL 
inhibited larval motility at percentages similar to those 
found for the negative controls with water and PBS 
(p > 0.05): 3.76% (± 0.5) and 5.38% (± 0.38), respectively; 
these values were significantly lower than that found for 
the positive control (p < 0.0001) (Figure 3A). Hence, high 
dilutions of the extract did not inhibit S. venezuelensis 
larval motility. It was not possible to count the number of 
specimens after treatment with the undiluted crude extract.
Figure 3B depicts the concentration-response curve of 
inhibition of S. venezuelensis larval motility as a function 
of the concentration of C. papaya seed extract, after 24 h 
of treatment. The extract exerted a statistically significant 
concentration-dependent effect (p < 0.0001), the intensity 
of which did not vary across the treatment periods; hence, 
the inhibitory action of the extract on larval motility was 
not time-dependent. The DL50 value determined at 24 h of 
treatment was 20.02 mg/mL. The crude extract lysed all the 
S. venezuelensis larvae added to the reaction tube, while 
the 566 mg/mL and 56.6 mg/mL concentrations partially 
degraded the larvae cuticle, as compared with the negative 
control containing water (data not shown).
DISCUSSION
Infections caused by soil-transmitted helminths 
represent an important public health problem, especially 
in developing countries18. In these locations, the interest in 
plant-based drugs for the treatment of parasitic diseases has 
increased progressively for many reasons, including serious 
side effects caused by the abuse and misuse of synthetic 
drugs and the difficultly of accessing pharmacological 
treatment19,20.
C. papaya seed extract has demonstrated promising 
anthelmintic potential against nematodes such as Ascaridia 
galli, Caenorhabditis elegans, Heterakis gallinarum, 
Meloidogyne incognita and Pheretima posthuma21,22. 
However, additional studies need to be performed with 
other human pathogenic parasite species that cause endemic 
infections in tropical areas throughout the world, such as 
Strongyloides stercoralis.
The present study demonstrated the in vitro anthelmintic 
activity of C. papaya seeds hexane extract against 
S. venezuelensis. We found that the extract has effectively 
suppressed egg hatching and larval motility, in accordance 
with the standards recommended by the World Association 
for the Advancement of Veterinary Parasitology16. The 
current in vitro findings with the C. papaya seed extract 
Figure 2 - Effect of Carica papaya seed hexane extract on the development and cuticle integrity of Strongyloides venezuelensis 
eggs. Fifty specimens were treated with the crude extract (a) or its 566 mg/mL concentration, (b) 5.66 mg/mL (c) and 5.66 mg/mL 
(d) dilutions, water (e), or PBS (f), for 48 h, at 28 ºC. Water and PBS were used as the negative controls. Images were captured at 
40x magnification, scale bar 40 µm.
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are corroborated by literature data on the in vivo effect of 
this preparation8. The aqueous extract of C. papaya seeds 
(i) suppress egg hatching and reduces the number of eggs 
produced by the nematodes A.galli, H. gallinarum and 
Trichostrongylus tenuis in infected birds23; and (ii) decreases 
the number of eggs per gram of faeces until the third day 
after sheep infection with endoparasites, presenting with 
72% efficiency in reducing the parasite load24. The 24 h 
treatment with oil from dry and fresh C. papaya seeds is 
highly efficient in controlling and reducing the lethality of 
the nematodes C. elegans and M. incognita; this nematicidal 
effect seems to be mediated by the oil component benzyl 
isothiocyanate21.
Many anthelmintic glycosides and alkaloids present in C. 
papaya seeds may interfere with the helminth homeostasis 
by inhibiting glucose uptake, sucrose transfer into the small 
intestine, nitrate generation, digestion and removal from the 
cuticle25. As helminths cannot store energy, damage to their 
cuticle leads to muscular paralysis and impairment of larval 
motility, resulting in parasite death in less than 24 h due to 
food deprivation26. It is possible that the alkaloid carpaine 
and the benzyl isothiocyanate present in C. papaya seeds 
exert the anthelmintic effect against the S. venezuelensis 
specimens, but it is necessary to isolate these compounds 
for new in vitro tests to validate this hypothesis. In any 
case, the anthelmintic effect of the hexane extract from 
C. papaya seeds against S. venezuelensis observed in this 
study makes it a potential candidate for the development of 
phytotherapeutic drugs to treat strongyloidiasis.
Figure 3 - Inhibition of Strongyloides venezuelensis larvae motility by Carica papaya seed hexane extract. (a) Percentage of inhibition 
of larval motility determined after treatment of 50 specimens with different extract dilutions for 24 h, at 28 ºC. Larval motility was 
determined by counting mobile and immobile larvae from a total of 50 specimens per sample. Concentrations: 566-0.0566 mg/mL. 
Negative controls: water and PBS. Positive control: ivermectin at 0.316 mg/mL. One-way analysis of variance (ANOVA) for parametric 
data and the Kruskal-Wallis test for nonparametric data were used to compare the counts of mobile and total larvae. (B) Non-linear 
regression curve for inhibition of larval motility as a function of extract concentration. Results are expressed as mean ± standard 
error of triplicate measurements. * p < 0.05; ** p < 0.01; *** p < 0.0001.
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